ABCF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.729400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.723800E-01
Normal-vs-Stage2
8.696200E-01
Normal-vs-Stage3
4.472600E-01
Normal-vs-Stage4
8.040600E-01
Stage1-vs-Stage2
8.264800E-01
Stage1-vs-Stage3
1.902210E-01
Stage1-vs-Stage4
9.648000E-01
Stage2-vs-Stage3
2.596400E-01
Stage2-vs-Stage4
8.934000E-01
Stage3-vs-Stage4
4.028400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.649600E-01
Normal-vs-AfricanAmerican
2.503200E-01
Normal-vs-Asian
4.501600E-01
Caucasian-vs-AfricanAmerican
3.093000E-01
Caucasian-vs-Asian
1.835790E-01
AfricanAmerican-vs-Asian
2.771500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.103000E-01
Normal-vs-Female
8.319600E-01
Male-vs-Female
5.880000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.947600E-01
Normal-vs-Age(41-60Yrs)
6.169200E-01
Normal-vs-Age(61-80Yrs)
8.752000E-01
Normal-vs-Age(81-100Yrs)
5.594200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.303600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.688600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.511800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.965780E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.404000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.934300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.338400E-01
Normal-vs-Daily Drinker
8.315200E-01
Normal-vs-Weekly Drinker
2.271600E-01
Normal-vs-Occasional Drinker
8.730000E-01
Normal-vs-Social Drinker
4.709400E-01
Non Drinker-vs-Daily Drinker
9.529400E-01
Non Drinker-vs-Weekly Drinker
1.718990E-01
Non Drinker-vs-Occasional Drinker
4.849200E-01
Non Drinker-vs-Social Drinker
1.473220E-01
Daily Drinker-vs-Weekly Drinker
1.786040E-01
Daily Drinker-vs-Occasional Drinker
4.890000E-01
Daily Drinker-vs-Social Drinker
1.305790E-01
Weekly Drinker-vs-Occasional Drinker
2.726800E-01
Weekly Drinker-vs-Social Drinker
4.747800E-01
Occasional Drinker-vs-Social Drinker
3.158400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.850600E-01
Normal-vs-Grade 2
7.010200E-01
Normal-vs-Grade 3
7.164800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.534400E-01
Grade 1-vs-Grade 3
1.500160E-01
Grade 1-vs-Grade 4
6.850600E-01
Grade 2-vs-Grade 3
3.027600E-01
Grade 2-vs-Grade 4
7.010200E-01
Grade 3-vs-Grade 4
7.164800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.517200E-01
Normal-vs-NonDiabetic
8.974400E-01
Diabetic-vs-NonDiabetic
8.370400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.453600E-01
Normal-vs-NoPancreatitis
9.006800E-01
Pancreatitis-vs-NoPancreatitis
6.450800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.056400E-01
Normal-vs-N1
8.502400E-01
N0-vs-N1
6.098800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.699610E-01
Normal-vs-TP53-NonMutant
5.414800E-01
TP53-Mutant-vs-TP53-NonMutant
3.525200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
